Recent Updates
Recently added Catalysts
MYGN Positive Sentiment Score: 70/100

Myriad Genetics to Present at 42nd Annual J.P. Morgan Healthcare Conference

Wednesday, January 3, 2024 1 min read
Key Takeaway: Myriad Genetics, Inc. will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024, at 4:30 PM PST. The event underscores Myriad's commitment to sharing advancements in genetic testing and precision medicine. The presentation will be accessible via a live webcast, with an archived version available later the same day. This engagement reflects Myriad's efforts to enhance patient care and reduce healthcare costs through innovative solutions.

Market Sentiment Analysis

POSITIVE FACTORS

  • Myriad Genetics is recognized as a leader in genetic testing and precision medicine.
  • The company is advancing health and well-being through innovative genetic tests.
  • The upcoming presentation indicates proactive engagement with investors.

Full Press Release Details

SALT LAKE CITY, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Myriad management will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10, 2024 at 4:30pm PST/ 7:30pm EST.
The presentation will be available through a live webcast in the investor relations section of Myriad’s website at investor.myriad.com. An archived edition of the presentation will be available later that day.
About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

Frequently Asked Questions

When will Myriad Genetics present at the J.P. Morgan Conference?

Myriad Genetics will present on January 10, 2024, at 4:30 PM PST.

How can I access Myriad's conference presentation?

The presentation will be available via live webcast on Myriad's investor relations page.

What does Myriad Genetics specialize in?

Myriad Genetics specializes in genetic testing and precision medicine.

What is the goal of Myriad Genetics?

Myriad aims to enhance health and well-being by assessing disease risk and guiding treatments.

Where can I find more information about Myriad Genetics?

More information is available on Myriad's website at www.myriad.com.

Tags: MYGN Viatris Investor Conferences Healthcare genetic testing precision medicine healthcare conference San Francisco
Last updated: Jan 3, 2024